UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number:    0-23272
 
NPS Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)

550 Hills Drive, 3rd Floor
Bedminster, New Jersey 07921
(908) 450-5300
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Class A Common Stock, par value $0.001 per share
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
Rule 12g-4(a)(1)
  
x
Rule 12g-4(a)(2)
  
¨
Rule 12h-3(b)(1)(i)
  
x
Rule 12h-3(b)(1)(ii)
  
¨
Rule 15d-6
  
¨
 
Approximate number of holders of record as of the certification or notice date:  1
 
Pursuant to the requirements of the Securities Exchange Act of 1934 NPS Pharmaceuticals, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 

Date:  March 5, 2015
NPS Pharmaceuticals, Inc.
 
 
  
 
/s/ Ellen Rosenberg
  
 
Name:
Ellen Rosenberg
  
 
Title:
Secretary
  

Nps (NASDAQ:NPSP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Nps.
Nps (NASDAQ:NPSP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Nps.